TechniScan 3D whole breast imaging system to be presented at SPIE conference

TechniScan, Inc.'s (OTC Bulletin Board: TSNI) cofounder and scientist-mathematician, James Wiskin, Ph.D, will be a presenting speaker at the SPIE Medical Imaging Conference in San Diego this weekend.

The TechniScan Warm Bath Ultra Sound (WBU™) system, capable of 3-dimensional whole breast imaging, is a result of Wiskin's and colleague David Borup's, Ph. D., groundbreaking work in the mathematics of inverse scattering.  Wiskin will be presenting "Inverse Scattering and Refraction Corrected Reflection for Breast Imaging" to attendees of the SPIE conference at the Town and Country Resort & Convention Center.

SPIE is a non-profit international society for the exchange, collection and dissemination of knowledge in optics, photonics and imaging engineering. SPIE organizes conferences, courses and exhibitions covering many aspects and applications of modern technology.

"The WBU system is the culmination of many years of concentrated effort. We are pleased to present our state-of-the-art technology and scientific development to such a distinguished group," said David Robinson, the company's chief executive officer.

SOURCE TechniScan, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Alzheimer's guidelines focus on risk, not diagnosis, in healthy adults